You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/ONqKpqCkYJVy/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

MEDIKAMENT HOCHWIRKSAM - In Dessau werden ERFOLGREICH Antikörperpräparate gegen Covid-19 eingesetzt

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 23:13 UTC on November 21st, 2021.

#antikoerperpraeparate
#casirivimab

Mihai Grigoriu

subscribers

BitChute Advertisement

WARUM IMPFPFLICHT? Mit dem Antikörpercocktail war im Oktober 2020 Donald Trump behandelt worden.
Casirivimab/Imdevimab, auch bekannt als REGN-COV-2, ist eine Kombination aus zwei monoklonalen Antikörpern, die zur Behandlung von COVID-19 eingesetzt wird. Der Arzneistoff ist seit November 2020 in den USA auf der Grundlage einer Emergency Use Authorization (EUA) zugelassen.
https://www.aerzteblatt.de/nachrichten/129034/COVID-19-Zwei-Antikoerperpraeparate-in-Europa-vor-der-Zulassung

LESS